RECRUITING

24GUT540 : Meeting of Breast Cancer Patients and Pathologists

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Historically, most pathologists have had little direct contact or communication with patients. In the past two decades, however, there has been a modest movement toward patient-pathologist visits in which pathologists review with patients their pathology slides. Very few studies of such encounters have been conducted. Most surveyed patients reported that the experience was positive and helpful to them. Our basic goal is to determine if such meetings are useful to patients; a secondary goal is to determine if such encounters are useful to, and practical for, pathologists.

Official Title

24GUT540: Opportunity for Breast Cancer Patients to Meet With a Pathologist to Review the Pathology Slides of Their Breast Samples

Quick Facts

Study Start:2025-07-10
Study Completion:2028-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07040514

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Must be at least 18 years of age.
  2. 2. Patients must have completed initial diagnosis visit with oncologist or surgeon.
  3. 3. Must have pathology slides and reports available for review.
  4. 4. Must be able to speak English.
  5. 5. Must be willing to participate in this research and will be provided with an information sheet.
  6. 6. Pregnant women are eligible as this research poses no risk of physical harm to the participant.
  1. 1. Patients \<18 years of age.
  2. 2. Patients with DCIS are ineligible.
  3. 3. Adults who are unable to provide written signature.
  4. 4. Patients from vulnerable patient populations, including infants, minors, those unable to provide informed consent, and those incarcerated or imprisoned at the time of enrollment.

Contacts and Locations

Study Contact

Research Nurse
CONTACT
800-639-6918
cancer.research.nurse@hitchcock.org

Principal Investigator

Edward J Gutmann, MD
PRINCIPAL_INVESTIGATOR
Dartmouth-Hitchcock Medical Center

Study Locations (Sites)

Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756
United States

Collaborators and Investigators

Sponsor: Dartmouth-Hitchcock Medical Center

  • Edward J Gutmann, MD, PRINCIPAL_INVESTIGATOR, Dartmouth-Hitchcock Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-10
Study Completion Date2028-06-01

Study Record Updates

Study Start Date2025-07-10
Study Completion Date2028-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer